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A bstract
M esial tem poral lobe epilepsy (M TLE) is associ-
ated w ith  severe neuronal death and reactive  
g liosis in  h ippocam pus. H ow ever, the m olecular 
m echanism s underlying these pathological chan -
ges rem ain unansw ered. ER K  has been reported  
chronically activated in reactive glia of hum an epil-
eptic h ippocam pus. In  the present study, w e in -
vestigated which of the downstream  signaling m ol-
ecules of ER K  w ould  be involved in  M TLE. W es-
tern b lot analysis dem onstrated  that C R EB  and  
p90RSK w ere strongly activated in M TLE patients. 
Increase in the active form s of CREB and p90RSK  
resulted not only from  the increase in  their phos-
phorylation levels but also from  the increase in  
the protein levels. Activation of CREB and p90RSK  
w as noted in  the w hole subfields of hippocam pus 
w ith  A m m on's horn sclerosis (A H S) representing  
a d istinctive cellu lar d istribution. H ow ever, the  
com m on m ajor change was present in proliferating  
reactive astrocytes. In  contrast, their activation  
w as not significant in adjacent tem poral lobes de-
spite the presence of a  num ber o f astrocytes ex-
pressing high levels of G FAP. Our results dem on -
strate that chronic activation C R EB  and p90R SK  
in  the epileptic  h ippocam pus m ay be closely as-
sociated w ith  the h istopathological changes of 
A H S.
Keywords: Ammon's horn sclerosis; CREB; ERK; 
epilepsy; p90RSK
In troduction
Mesial temporal lobe epilepsy (MTLE) is the most 
common partial epilepsy, which is frequently resistant 
to antiepileptic drug therapy. Ammon's horn sclerosis 
(AHS) is the most common pathological substrate for 
drug-resistant MTLE, which is characterized by the 
histopathological changes of hippocampus consisting 
of neuronal cell death, enhanced neurogenesis, axo-
nal sprouting, and reactive gliosis (Babb and Brown, 
1987). However, the molecular mechanisms involved 
in the genesis and the progression of AHS remain 
elusive.
  Elucidation of the signaling molecules activated 
abnormally in MTLE patients is indispensable not only 
for the understanding of its pathogenesis but also for 
the search of the potential therapeutic target. In hu-
man epileptic hippocampal tissue, extracellular signal- 
regulated kinase (ERK) has been reported to be chro-
nically activated in reactive glia (Mandell and Vanden-
Berg, 1999). However, which of the downstream ef-
fectors of ERK are involved in this hippocampal path-
ology has not been defined. Among the possible down-
stream targets Elk, c-AMP response element binding 
protein (CREB), and p90RSK were specially evalu-
ated in this study because they have been previously 
reported to play a critical role in hippocampus as a 
downstream of ERK in relation to neuronal excitation 
(Xia, et al., 1996; Angenstein, et al., 1998; Atkins, et 
al., 1998).
  We demonstrate here that cyclic AMP regulatory 
element binding protein (CREB) and 90-kDa riboso-
mal S6 kinase (p90RSK) are actively expressed in 
epileptic hippocampus. Major changes were noted in 
the proliferating reactive astrocytes rather than in exi-
sting neurons. Our results demonstrate that not only 
the increase in the phosphorylation levels of CREB 
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and p90RSK but also the increase in their total ex-
pression levels independently of the activated ERK 
may contribute to their activation.
M ateria ls and M ethods
H ippocam pal specim ens
Fourteen surgical specimens from patients with chro-
nic medically refractory MTLE (age: 29±7 year-old, 
duration of epilepsy: 16±8 years) were examined. 
The epileptogenic region was localized to the mesial 
temporal lobe in all patients by continuous electro-
encephalography-video monitoring. The concomitantly 
taken temporal cortex adjacent to hippocampus was 
also evaluated to investigate the regional differences 
in six patients. As control specimens, five human con-
trol hippocampal specimens were obtained at autopsy, 
with post mortem intervals ranging from 6-24 h. All 
tissues were fixed in buffered neutral paraformalde-
hyde and processed routinely into paraffin, or frozen 
by liquid nitrogen and subsequently stored in -70oC 
deep freezer. All procedures were conducted in ac-
cordance with consent of the patients or family mem-
bers, and were approved by the Ethics Committee of 
the Severance Hospital, Seoul, Korea.
W estern b lot analysis
Frozen hippocampal tissue (control = 3, patients = 6) 
was homogenized in RIPA buffer. After centrifugation, 
60 µg of protein was electrophoresed through 12% 
acrylamide sodium dodecylsulfate-denaturing gels. The 
gel was transferred to an immobilon membrane (Milli-
pore, Bedford, MA), and probed with anti-total or- 
phospho specific monoclonal antibody to ERK, CREB, 
Elk-1, or p90RSK (NEB, Beverly, MA) as recom-
mended by the manufacturer. Detection of the specific 
protein was performed using the enhanced chemilu-
minescence system (Amersham Pharmacia Biotech, 
Buckinghamshire, UK).
Im m unohistochem istry
All hippocampal specimens were coronally dissected 
along the septotemporal axis. After deparaffinization 
in xylene and alchohol, quenching of endogenous 
peroxidase activity using 1% hydrogen peroxide and 
then microwave antigen enhancement (in 10 mM 
citrate buffer (pH 6.0) for 10 min at 1.15 kW) was 
performed. Subsequently, the slide was incubated with 
anti-phospho specific monoclonal antibody of ERK 
(1:200), CREB (1:100), or p90RSK (1:100) in dilution 
solution (DAKO, Glostrup, Denmark) overnight, or 
anti-glial fibrillary acidic protein (GFAP) antibody (1: 
400; Sigma) for an hour at room temperature. Bio-
tinylated anti-rabbit secondary antibody with avidin- 
biotin protocol (DAKO) was used for detection. Then 
counterstaining was performed using Hematoxylin.
Q uantification of im m unoreactive g lia l cells
of activated  C R EB  and p90R SK  in  h ippocam pus
For the determination of immunoreactive glial cell 
densities against respective antibodies all specimens 
were evaluated. Cell counting was performed in five 
different areas of hippocampal subfield cornus am-
monus (CA) under the light microscope at a magni-
fication of 200× (Olympus, Tokyo, Japan). Glial nu-
clei were counted in each unit area of a 500 µm ×
500 µm rectangle using an ocular grid calibrated with 
a stage micrometer. Immunoreactive glial cell den-
sities were expressed as a percentage relative to the 
total number of glial cells in each unit area. The data 
were analyzed statistically using the SPSS Version 
9.0 (SPSS inc., Munich, Germany).
R esu lts
A ssessm ent of the increased activ ities o f
ER K , C R EB  and p90R SK  in  hum an TLE
by w estern b lot analysis
Western blotting using the phospho-specific ERK anti- 
body demonstrated that activation of ERK was noted 
F ig u re  1 . W estern blot analysis to detect the activated forms of
ERK, CREB, and p90RSK in the hippocampus of the mesial tem-
poral lobe epilepsy (MTLE) patients. Cell extracts were prepared 
from the hippocampus of three controls and six MTLE patients using
homogenizer. A total of 60 µg of proteins was loaded for each lane
of 12% SDS-polyacrylamide denaturating gel. Significantly increased
activities of phospho-ERK, CREB, and p90RSK activities were detec-
ted in epileptic hippocampus but not in normal control. Loading of 
equal amount of proteins in each lane was confirmed by western
blot analysis of β-actin. C, control; T, patient with MTLE.
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F ig u re  2 . Immunohistochemial detection of GFAP, phospho-ERK, phospho-CREB, and phospho-p90RSK in the epileptic hippocampus and
control. (A-C) Low (20×) and higher magnification photomicrograph (400×) of cornus ammonus (CA) and dentate gyrus (DG) region of
mesial temporal lobe epilepsy (MTLE) patients shows severe neuronal loss and astrogliosis revealing intense immunoreactivity against GFAP
in the fibrillary background and the cytoplasm of reactive astrocytes. (D-F) Its corresponding section demonstrates the profound activation
of ERK in all subregions of hippocampus (20×). Strong immunoreactivities against phospho-ERK were observed both in the process and
nucleus of reactive astrocytes (arrows), but not in neurons of CA and DG (arrowheads, 400×). (G and H) The corresponding section shows 
the profound activation of CREB only in the nucleus of reactive astrocytes (arrows), however, no immunoreactivity was detected in the
residual neurons in CA and DG (arrowheads, 400). (I) In the histologically normal control hippocampus phospho-CREB staining was not
observed (400×). (J and K) The corresponding section of AHS reveals intense active- p90RSK immunostaining in the perinuclear cytoplasm
of both reactive glial cells (arrows) and remaining neurons showing granular appearance in CA and DG subregion (arrowheads, 400×).
(L) In control specimen faint and homogenous immunoreactive pattern was observed in neuron (arrowheads) and part of quiescent astrocytes
(arrow, 400×).
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only in the specimens of epileptic patients (Figure 1). 
Interestingly, the expression level of total ERK in 
MTLE patients' hippocampus was rather lower than 
that in the control specimen. These results suggest 
that activation of ERK in MTLE patients might be 
mainly controlled by phosphorylation. Of the tested 
possible downstream signaling molecules of ERK 
pathway, CREB and p90RSK demonstrated a signi-
ficant increase in their activities when assessed by 
western blot analysis using the specific antibodies 
recognizing their respective active form. We were 
unable to detect any changes in the activities of Elk-1 
(data not shown). Interestingly, the total protein levels 
of CREB and p90RSK were also increased in the 
epileptic hippocampus. These results suggest that this 
activation of CREB and p90RSK may be primarily 
derived from the increase in their protein levels rather 
than the increase in their activities through phos-
phorylation. Therefore, our results suggest that both 
CREB and p90RSK in the AHS may be chronically 
activated, although their activities may not be ex-
clusively dependent on ERK activities (Figure 1).
C ellu lar d istribution of active ER K , C R EB  and
p90R SK  in  the epileptic h ippocam pus
The characteristic histopathological features of AHS 
consisting of substantial loss of neurons and in-
creased number of astrocytes were consistently found 
in all MTLE specimens, which was most extensive in 
the CA subfield of hippocampus (grade 3 in four and 
grade 4 in ten patients) (Wyler, et al., 1995). GFAP 
immunoreactivity was markedly increased in the pro-
cesses and cytoplasm of astrocytes in the hippo-
campus from MTLE patients providing the evidence 
of severe reactive gliosis (Figure 2A-C). However, in 
the control hippocampus showing normal morpho-
logical features, GFAP expression was only faint (data 
not shown).
  Next, we examined the cellular origins representing 
high activities of ERK, CREB and p90RSK in MTLE 
patients' hippocampus by immunohistochemical analy-
sis using the specific antibodies recognizing the acti-
vely phosphorylated proteins. While the immuore-
activity of active ERK was observed not only in the 
nucleus but also in the process of astrocytes (Figure 
2D-F), highly active CREB was localized only in the 
nucleus of the reactive astrocytes in the epileptic 
hippocampus (Figure 2G and H). None of the existing 
neurons in CA and dentate gyrus (DG) revealed any 
immunoreactivity for ERK or CREB. These results 
suggest that CREB may play a role in the astrogliosis 
leading to AHS.
  In contrast, immunohistochemical analysis to detect 
the active form of p90RSK demonstrated intense ac-
tivity of p90RSK in the perinuclear cytoplasm of the 
reactive glial cells (Figure 2J and K). Interestingly, 
active p90RSK immunoreactivity with granular mor-
phology was also noted in the cytoplasm of the re-
maining neurons. On the other hand, a diffuse pattern 
of immunoreactivity against active p90RSK but with 
a much less intensities was detected in the majority 
of neurons and some quiescent astrocytes of control 
hippocampal specimen (Figure 2L). These results 
suggest that p90RSK activity in the existing neurons 
may be maintained at a considerable level in both 
normal and epileptic hippocampus. However, the 
quantitative analysis of the cells expressing activated 
p90RSK protein revealed a much higher proportion of 
immunopositive glial cells in the CA region from the 
MTLE patients than the control (Figure 3). These 
results seem to suggest a link between the increased 
p90RSK activity and reactive gliosis of epileptic hip-
pocampus, and its possible involvement in the path- 
F ig u re  3 . (A and B) The quantitative analysis of the immunoreactivity against phospho-CREB and p90RSK antibody. The proportion of im-
munopositive glial cells of activated CREB and p90RSK among total number of counted glia in the observed cornus ammonus (CA) region
was markedly increased in mesial temporal lobe epilepsy (MTLE) patients. *P ＜ 0.05. C, control; T, patient with MTLE.
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ogenesis of AHS.
D istribution in  the adjacent tem poral lobe
To investigate whether activation of ERK, CREB or 
p90RSK is regionally specific for the epileptic hippo-
campus with sclerosis, the immunoreactivitiy of these 
signaling molecules were examined in six histo-
logically normal adjacent lateral temporal lobes (in-
ferior temporal gyrus) of MTLE patients. The majority 
of the astrocytes both in gray and white matter were 
reactive with anti-GFAP antibody (Figure 4A). How-
ever, the activated form of ERK was detectable only 
in subpial astrocytes (Figure 4B). In addition, CREB 
and p90RSK did not show any detectable extent of 
activation (Figure 4C and D). Taken together, our 
results suggest that chronic activation of ERK, CREB, 
and p90RSK may be closely associated with the 
ongoing neuropathologic process for epileptic hippo-
campus.
D iscussion
The identification of signal transduction events as-
sociated with MTLE in hippocampus is very important 
both for understanding of the pathomechanisms in-
volved in AHS and for designing future therapeutic 
interventions.
  In human epileptic hippocampal tissue ERK has 
been reported to be chronically activated in reactive 
glia (Mandell and VandenBerg, 1999). ERK has been 
known to regulate diverse functions, such as cell 
growth, proliferation, differentiation, and apoptosis 
(Schaeffer and Weber, 1999). Moreover, ERK is an 
integral component of cellular response to glutama-
tergic stimulation (Bading and Greenberg, 1991; Fiore, 
et al., 1993), and mediates seizure-induced hippo-
campal neuronal death in in vitro epilepsy model (Mur-
ray, et al., 1998).
  Consistent with the previous report by Mandell and 
WandenBerg (1999), we also observed a significant 
activation of ERK in the hippocampus of MTLE pa-
tients. In the present study, we clearly demonstrated 
that the primary underlying mechanism leading to 
ERK activation is the increase of phosphorylation 
level, since the total expression of ERK in control 
specimens was higher than that in MTLE patients. 
Among the tested signaling molecules associated with 
ERK pathway, both CREB and p90RSK revealed a 
significant activation in the hippocampus, indicating 
their possible role in the pathogenesis of AHS. How-
ever, the activation mechanism of CREB and p90RSK 
may not be exclusively dependent on the activated 
ERK. Compared with the control specimens, the 
expression levels of total CREB and p90RSK protein 
were significantly elevated in the hippocampus of 
MTLE patients. Especially the expression pattern of 
total CREB protein was almost paralleled with the 
activation profile of CREB in western blot analysis 
using hippocampal homogenates. While ERK, CREB 
and p90RSK were all activated in astrocytes, signi-
ficantly high activity of p90RSK was also localized in 
neurons. These results suggest that another activation 
mechanism of CREB and p90RSK may exist inde-
pendently of ERK pathway, possibly through the 
transcriptional or translational control. It was un-
expectable that activation of CREB and p90RSK were 
not identical to that of ERK, because CREB has been 
known to be activated ERK-dependently in neuronal 
excitatory gene expression (Sheng et al., 1990; Xia 
et al., 1996) and p90RSK be usually located down-
stream of the ERK pathway in response to virtually 
all extrcellular signaling molecules that stimulate the 
ERK pathway (Blenis, 1993).
  The significance of reactive astrocytes in the epil-
eptogenesis has been raised recently. They regulate 
neuronal excitability not only by the clearance of ex-
tracellular potassium and glutamate but also by the 
release of inhibitory transmitters. Furthermore, they 
promote the mobilization of intracellular calcium lead-
ing to more neuronal damage and formation of dys-
trophic neurites by the expression of molecules with 
high neurite promoting activity (Duffy and MacVicar, 
F ig u re  4 . Immunohistochemical detection of GFAP, phospho-ERK,
phospho-CREB, and phospho-p90RSK in the adjacent lateral tem-
poral lobe (200×). (A) In the examined lateral temporal cortex, 
inferior temporal gyrus, the majorities of the astrocytes both in gray
and white matter were strongly reactive with anti-GFAP antibody. 
(B) However, phospho-ERK immunoreactivity was only noted in the
limited area, subpial region. (C and D) Phospho-CREB and phospho-
p90RSK did not demonstrate a detectable level of immunoreactivity.
A B
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1999; Grisar, et al., 1999; Heinemann, et al., 1999). 
However, the signaling molecules involved in the 
reactive gliosis associated with epilepsy have not 
been extensively investigated. Our immunohistohemi-
cal study demonstrated that the activation of CREB 
and p90RSK in hippocampus of MTLE patients might 
be closely associated with reactive gliosis. Both CREB 
and p90RSK demonstrated a notable activation in 
glial cells of MTLE patients. In chronic epilepsy, ex-
cessive neuronal activation by epileptic discharges 
renders cells exposed to the immoderate amount of 
glutamate and calcium resulting in the execution of 
neuronal cell death and synaptic sprouting (Heine-
mann, et al., 1986; Olney, et al., 1986). CREB has 
been reported to be a critical mediator of calcium- 
and glutamate-dependent gene expression (Sheng, et 
al., 1990; Xia, et al., 1996). However its function in 
astrocytes has not been investigated. In this study, 
the active form of CREB was exclusively localized in 
the nuclei of astrocytes of epileptic hippocampus, 
suggesting its possible role as a transcription factor 
(Martin, et al., 1997). Interestingly, intense immuno-
reactivity of phospho-p90RSK with granular morpho-
logy was noted in the glial cytoplasm of MTLE pati-
ents in our study. Previously, Angenstein et al (1998) 
has reported that glutamate initiated translocation of 
p90RSK to polyribosomes for protein synthesis in 
hippocampus. Therefore, it is expected that p90RSK 
may play a possible role in human epileptic hippo-
campus via regulation of protein synthesis. However, 
to further elucidate the significance of chronic acti-
vation of CREB and p90RSK in epileptic hippocampus 
and their relationship with ERK pathway, and to 
evaluate the ERK pathway as the potential thera-
peutic target of MTLE, further studies using animal 
models and in vitro experiments would be required.
A cknow ledgem ent
This work was supported by a grant from the Ministry 
of Health and Welfare (02-PJ1-PG3-21301-0019, to BI 
Lee) and from the KOSEF/BDRC Ajou University 
(R11-1998-052-08005, to KS Choi).
R eferences
Angenstein F, Greenough WT, Weiler IJ. Metabotropic glu-
tamate receptor-initiated translocation of protein kinase 
p90rsk to polyribosomes: a possible factor regulating sy-
naptic protein synthesis. Proc Natl Acad Sci USA 1998;95: 
15078-80
Atkins CM, Selcher JC, Petraitis JJ, Trzaskos JM, Sweatt 
JD. The MAP kinase cascade is required for mammalian 
associative learning. Nature Neurosci 1998;1:602-9
Babb TL, Brown WJ . Pathological findings in epilepsy. In 
Surgical treatment of the epilepsies (Engel J, Jr, ed), 1987, 
511-540, Raven press, New York NY
Bading H, Greenberg ME. Stimulation of protein tyrosine 
phosphorylation by NMDA receptor activation. Science 1991; 
253:912-4
Blenis J. Signal transduction via the MAP kinases: proceed 
at your own RSK. Proc Natl Acad Sci USA 1993;90:5889-92
Duffy S, MacVicar BA. Modulation of neuronal excitability by 
astrocytes. Adv Neurol 1999;79:573-81
Fiore RS, Murphy TH, Sanghera JS, Pelech SL, Baraban 
JM. Activation of p42 mitogen-activated protein kinase by 
glutamate receptor stimulation in rat primary cortical cultures. 
J Neurochem 1993;61:1626-33
Grisar T, Lakaye B, Thomas E, Buttendorf L, Minet A. The 
molecular neuron-glia couple and epileptogenesis. Adv Neurol 
1999;79:591-601
Heinemann U, Konnerth A, Pumain R, Wadman WJ. Ex-
tracellular calcium and potassium concentration changes in 
chronic epileptic brain tissue. Adv Neurol 1986;44:641-62
Heinemann U, Gabriel S, Schuchmann S, Eder C. Contri-
bution of astrocytes to seizure activity. Adv Neurol 1999;79: 
583-90
Mandell JW, VandenBerg SR. ERK/MAP kinase is chronically 
activated in human reactive astrocytes. Neuroreport 1999;10: 
3567-72
Martin KC, Michael D, Rose JC, Barad M, Casadio A, Zhu 
H, Kandel ER. MAP kinase translocate into the nucleus of 
the presynaptic cell and is required for long-term facilitation 
in Aplysia. Neuron 1997;18:899-912
Murray B, Alessandrini A, Cole AJ, Yee AG, Furshpan EJ. 
Inhibition of the p44/42 MAP kinase pathway protects hippo-
campal neurons in a cell-culture model of seizure activity. 
Proc Natl Acad Sci USA 1998;95:11975-80
Olney JW, Collins RC, Sloviter RS. Excitotoxic mechanisms 
of epileptic brain damage. Adv Neurol 1986;44:857-78
Schaeffer HJ, Weber MJ. Mitogen-activated protein kinases: 
specific messages from ubiquitous messengers. Mol Cell Biol 
1999;19:2435-44
Sheng M, McFadden G, Greenberg ME. Membrane depolari-
zation and calcium induce c-fos transcription via phos-
phorylation of transcription factor CREB. Neuron 1990;4:571- 
82
Wyler AR, Hermann BP, Somes G. Extent of medial tem-
poral resection on outcome from anterior temporal lobec-
tomy: a randomized prospective study. Neurosurgery 1995; 
37:982-91
Xia Z, Dudek H, Miranti CK, Greenberg ME. Calcium influx 
via the NMDA receptor induces immediate early gene trans-
cription by a MAP kinase/ERK-dependent mechanism. J 
Neurosci 1996;16:5425-36
